chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About five to ten minutes after I received my first shot, I started to feel like my throat was closing a little. I knew it wasn?t an allergic reaction because I could still speak, but I also became very dizzy and sweaty. I stood up to go see the nurse and she took my blood pressure and it was slightly higher than normal and my heart rate was extremely elevated. I sat down on a stretcher and felt incredibly light headed and gained a metallic taste in my mouth. I also felt very nauseous and started experiencing chest pains. It felt like a panic attack but more severe and more sudden. My throat felt very tight but I could still talk, and my cheeks felt like they were on fire. My face was bright red. They gave me some water and monitored me some more and encouraged me to go to the hospital, but my symptoms subsided after about 35 minutes. After that I just felt tired and didn?t have any more symptoms.
10/29/21 presents to ED after having URI symptoms for 3 to 4 days and testing positive for COVID. PMH of diabetes, CAD, HFoEF, A. fib on Eliquis, rectal carcinoma, hyperlipidemia.
11:30 am called for dizziness. PR: 92. Pt stated she feels better but still dizzy. Walked to the observation area. Layed on stretcher. @ 11:46 am PR  84 , RR 18, BP 125/80, O2% 98, x1 apple juice.@ 11:55 PR 82,  RR 20 , BP 131/89,  O2% 98. @ 12:04 pm PR 88 , RR , 20, BP 127/84, O2% 98. @ 12:08 pm Pt expressed feeling well and had been walked out to Parking lot.
Patient is fully vaccinated and boosted.  COVID positive on admission to the hospital.  Patient presented to the ED per complaints of fatigue,  flank pain, bradycardia, hypotension & hypoxia from their PCP's office. Work up was concerning for COVID pneumonia, Diverticulitis, AKI, COPD exacerbation, CHF exacerbation or possible Sepsis. Broad spectrum antibiotics, IV fluid resuscitation, breathing treatments, rate control, & blood cultures were all initiated & drawn. Patient improved quickly oxygenating appropriately on room air with appropriate vitals & responding appropriately to interventions. Discharge plans were initiated with continued outpatient antibiotics to treat diverticulitis.   Medications: albuter, aspirin, bumetanide, carvedilol, fluticasone, furosemide, ipratropium, tamsulosin and warfarin. Cr 1.62,   PLTS 42-132, D dimer 759.  Discharged home.
Patient called my office and reported to me that she started having numbness and tingling in the right arm that received the vaccine approximately 4 hours after it was given. Symptoms lasted for approximately 30 hours and then resolved
skin felt like itchy pinpricks all over; tiredness; dizziness/lightheadedness; This is a spontaneous report from a contactable Consumer (Patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), via an unspecified route of administration at left arm on an unknown date in Jan2021 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included Chronic Sinusitis, patient's known allergies: Systemic steroids, Amoxicillin, Prednisone, Cortizone, Levofloxacin, Famotidine, Apples, Pineapples, Shellfish. Concomitant medication included hydrochlorothiazide, lisinopril (LISINOPRIL AND HYDROCHLOROTHIAZIDE), colecalciferol (D3), cyanocobalamin (VITAMIN B12). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Skin felt like itchy pinpricks all over, tiredness, dizziness and lightheadedness for about 2 days happened eight days after receiving first dose on an unknown date in Jan2021. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date.
Within 1 hour of the vaccination, patient was feeling lightheaded and dizzy, but this dissipated within the subsequent 30-60min The night of the vaccine he woke feeling uncomfortable, "clammy", and with diffuse myalgias.  He then went back to sleep and awoke around 1am with "drenching sweats".  Tried to walk to parents' room but peripheral vision became black, ears were ringing, and he felt like he couldn't do anything, then fainted.  No feelings of chest pain or palpitations preceding event. Parents report that he was unresponsive for 3-4 minutes, uncertain if he had a pulse, appeared "blanched" in his face.  Called EMS EMS reports HR 30-40 upon arrival, consciousness returning slowly.
got Moderna also has ringing in the ears now; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (got Moderna also has ringing in the ears now) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (got Moderna also has ringing in the ears now). At the time of the report, TINNITUS (got Moderna also has ringing in the ears now) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided. Treatment information was not provided.   This case was linked to MOD-2022-446784 (Patient Link).
pt experienced severe dizziness shortly after receiving vaccination. pt was helped to the ground where she laid back and put her feet up. she experienced immediate relief. she stayed in that position for another 10 minutes and was able to sit up on a chair for an additional 15 minutes of observation
Patient woke 7/10/17 feeling very tired. Developed a spot on her tongue that felt numb. This area of numbness increased over the next couple days to affect her airway and swallowing. On 7/11/17, she developed a severe headache, facial and eyelid droop to the left side of her face, difficulty walking and pain to her left arm and leg. Patient went to the local ER the night of 7/11/17. Labs revealed a decreased potassium level according to patients mother. Values unknown. PA in ER told the patient and her mother that she might have dehydration and possible heat stroke. Pt sent home. Symptoms continued to worsen and patient was driven by family to Clinic where she went through the ER early.
This infant was immunized 10/12/00 with DTAP, MMR, Varicella, and HIB. She was seen by her pmd 10/13/00 for fever of 102.2. Then she was started on Augmentin. The patient developed a rash on her body 10/14/00, the antibiotic was discharged, the rash worsened over the weekend. The infant was seen by her pmd again, there was a maculopapular rash, blisters in her mouth ,  lips, and genitalia. Took about three days to recover fully.
Break through COVID infection. Woke up 1/5 with sore throat. On 1/6 I had more sore throat irritation and body aches. On 1/7 I took a home test as I felt miserable. Test was possibly positive, but the line was very faint.
Patients were administering 0.25 ml instead of 0.5 ml to uncompromised adults/approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patients were administering 0.25 ml instead of 0.5 ml to uncompromised adults/approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patients were administering 0.25 ml instead of 0.5 ml to uncompromised adults/approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patients were administering 0.25 ml instead of 0.5 ml to uncompromised adults/approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patients were administering 0.25 ml instead of 0.5 ml to uncompromised adults/approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster).    No concomitant medications were reported. No treatment details were reported.  Patient received underdose of 0.25 ml Moderna Bivalent Booster.  It was reported that, nurses had no standing orders other than what they had for the second booster, when first administering Bivalent boosters. So, they assumed the same dose as the second booster, hence they were administering 0.25 ml instead of 0.5 ml to uncompromised adults.  It was reported that approximately 100 patients were administered an invalid dose of the Moderna COVID-19 bivalent booster.   This case was linked to US-MODERNATX, INC.-MOD-2022-646512 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-646512:Same reporter (Master case)
Tinnitus, dizziness since the day after I was vaccinated. I thought I should report it
No additional AE reported; HCP reporting VAQTA, PEDVAXHIB, and ROTATEQ were administered after a temperature excursion. Caller stated she did not have the exact dates of administration nor the names of the patients involved. No additional information provided. No additional AE; This spontaneous report was received from a Health Care Professional and refers to a 15-month-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 06-DEC-2022, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) intramuscular injection, in left thigh, lot #U031544, expiration date: 23-JUN-2024, administered intramuscularly for prophylaxis (strength was not provided).  The administered dose of the vaccine experienced a temperature excursion (product storage error) since 01-DEC-2022. The vaccine administered were stored at temperatures excursion of 47.9 Fahrenheit (storage in clinical practice) for 47 minutes. Data logger was involved.  No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA001175: US-009507513-2301USA009088: US-009507513-2301USA009024: US-009507513-2301USA009110: US-009507513-2301USA009878: US-009507513-2301USA009918: US-009507513-2301USA009933: US-009507513-2302USA000723: US-009507513-2302USA000872: US-009507513-2302USA000721: US-009507513-2302USA000858: US-009507513-2302USA000721:
Patient got up from the floor too fast watching mom get shot. Patient tolerated his shot well, walked six steps crumbled and hit his elbow when he fell, applied ice to his neck. Never past out, got weakened, has had no supper. Kept for 15 minutes, ate candy. BP 120/80 P84.
I got a muscle ache on the injection site 4-5 hours after the jabbing, and a febrile (97.4), tiredness and headache the next day of it. I took a NSAIDS tablet 3-4 hours after showing up febrile. I almost recovered with a little bit of a headache 2 days later of the injection.
Difficulty in breathing, shortness of breath, shivering, fast heartbeat, coughing, headache, blocked nose.
BlurredVision, Headache, Leftsided facial tingling and weakness. Left arm weakness and grip
was given an adult dose; an 18 year old female was given an adult dose; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 18-year-old female patient who received HAV (Havrix adult) (batch number KM72C, expiry date 18th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st February 2022, the patient received the 1st dose of Havrix adult and Havrix Pre-Filled Syringe Device. On 1st February 2022, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that the 18 years old patient was given an adult dose of Havrix, which led to overdose and adult product administered to child. No symptoms were reported. The reporter consented to follow-up.
This spontaneous report was received from a physician referring to a 70 year old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date the patient was vaccinated with PNEUMOVAX 23 prefilled syringe, lot # N023651, expiration date: 20-MAY-2019 (frequency, dosage and route of administration were not reported) for prophylaxis. The patient experienced a hot red rash (like a welt at the injection site) with a slight fever right after injection. At the time of this reaction, the patient was still in the physician's office. The physician recommended ZYRTEC for the reaction. The patient has not reported her condition since the PNEUMOVAX 23 administration; so the outcome of injection site rash and pyrexia was unknown. This is one of several reports received from the same reporter and the adverse event quality investigation process was requested as the physician "stopped using that box" (lot # N023651 and expiration date: 20-MAY-2019) of prefilled syringes after the second adverse reaction. The reporter considered injection site rash and pyrexia as life-threatening events and also be related to PNEUMOVAX 23. Sender's Comments: US-009507513-1711USA010076: US-009507513-1711USA010085.
Patient describes swelling in all joints, numbness and tingling in hands and feet distally. Generalized rash over legs and arms, swollen cervical lymph nodes and cervical neck achiness.
Sudden onset of uncontrollable shaking for 30 to 45 minutes, slight nausea, light headedness. I was about to transport my husband to ER when symptoms subsided as quickly as they started. My husband felt feverish, but had no fever. Left upper arm was slightly swollen and sore at 6:00 AM this morning.  My husband felt slightly off after the first vaccination.
Fever (T increase to 104) on 1/3. T ranged 101-104 1/4-1/6. 1/6 developed red raised rash on face which spread to all body parts over the next day. Seen in clinic on 1/7/04.
I started feeling symptom's 01JAN2023 in the evening they were achy low grade fever one hundred point five with a very mild headache with some respiratory issues that were there the next day. I went to an urgent care center and was prescribed PAXLOVID and was just achy and not feeling well the next few days.
Erythema, tenderness/pain, itching at injection site beginning immediately after injection continuing through > 48 hrs.
Itchy rash at the forearm; Red rash at the forearm; hip pain; Low back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Low back pain), RASH PRURITIC (Itchy rash at the forearm), RASH (Red rash at the forearm) and ARTHRALGIA (hip pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced BACK PAIN (Low back pain) and ARTHRALGIA (hip pain). On 26-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash at the forearm) and RASH (Red rash at the forearm). At the time of the report, BACK PAIN (Low back pain) had not resolved and RASH PRURITIC (Itchy rash at the forearm), RASH (Red rash at the forearm) and ARTHRALGIA (hip pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was reported.  Treatment included using heating pad for low back pain.   This case was linked to MOD-2021-062559 (Patient Link).
had syncope approx. 15 mins after injection - after pt aroused she was noted to right have facial droop, slurred speech, dysarthria, 2/5 strength to RLE, 4/5 strength to RUE.
Chills, body aches, fever of 101.5, profuse sweating, insomnia
Brook out in rash 8 days after shot, and redness and rash nickel size 1 1/2 - 2 cm at site day 9. Intermittent fever of to 101.5 since day 8 and fussy at night x couple of nights.
The severe symptoms include chest pain, heart pain, paleness, weakness, a fast heart beat, muscle twitching (spasms), muscle pain, whole body uncomfortable, headache. The symptoms are obvious immediately after the flu shot. No treatments and the symptoms stay the same and become worse.
Drive through clinic. No problem getting shot. Two - five minutes after dose while waiting after the shot, I felt a warm / hot  sensation go through body up to neck, like after getting dye injected into vein for venogram or other test requiring dye. Felt like might become short of breath but didn't. By the time I walked into clinic B/P was high B/P 166/100. I run high B/P but it is controlled with meds. Warm feeling disappated within 1 - 2 minutes with some warmth in neck felt again a minute or so  later.
devel fever lasting 12hr diarrhea lasting 24hr, inj site red, swollen, hot & sore followed by bruising of arm;lasted 1wk;
Developed  gout in right hand and right foot.  PCP prescribed Indomethecin.  Condition continues after multiple weeks.
Immediately got left sided eye pain and nausea / an hour and a half later got chest tightness and pain, which lasted intermittently 5 days.  No reaction at vaccine site on the left arm.
The employee reports that during the early morning I began with respiratory distress, severe pain at the base of the lung. Patient suffers from chronic asthma, thyroid cancer and masses in both lungs. The patient reports that her internist, Dr., Dr., pulmonologist, and Dr. told her that she could be vaccinated. Xopenex respiratory therapy and other routine asthma medications were administered at the time of symptoms. As of today, March 11, 2021, there are no symptoms.
Vaccine at 1515 & by 2130 vomiting & head was spinning non-stop & pain in (R) arm where received injection (limited ROM in arm); had some vision problems too. Lasted for approx. 18 hours.
Moderna COVID-19 Vaccine EUA My appointment was scheduled at 1:15 on March 11, 2021  /  I received my vaccination at 1:55  /  Between 5:30 and 6:00 pm the same evening  I noticed my heart was racing.  I experienced some shortness of breath.  This continued until 3:30 am.   I had another episode on Sunday March 14th.  It did not last as long.  I had another episode on March 17th this too only lasted a few hours.   I have a lot of food allergies and carry an epi pen.  I initially felt fine after the vaccination.  I informed the nurse of my allergies and was monitored for 30 minutes after my vaccine.  I did not seek medical attention for the heart racing and shortness of breath.  I was not aware it was a considered an allergic reaction.
Had a pruritic rash that was diffuse, confluent, fixed, erythematous maculopapular rash on neck, torso, upper and lower extremities. KENALOG 100 mg IM given, antihistamines and ZANTAC twice daily. On 10/16/10 rash is worse and now inside her mouth, she was sent to ER. ER gave her another steroid shot and DEPOMEDROL pak. Seen on 10/18/10 for follow up and another scheduled on 10/21/10.
Very light site tingle; Very slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Very light site tingle) and HEADACHE (Very slight headache) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PARAESTHESIA (Very light site tingle) and HEADACHE (Very slight headache). On 24-Feb-2021, HEADACHE (Very slight headache) had resolved. At the time of the report, PARAESTHESIA (Very light site tingle) outcome was unknown.
patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    Concomitant medication was not provided. 196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Non-Significant follow up: Age group updated
On 10-20-12 received FLUZONE (L) anterior thigh. Started swelling and redness within 2 hours. Increased size on 10-22-12, mild itching. Office visit on 10-22-12. Symptomatic treatment cool compresses. Monitor for worsening symptoms.
Patient developed a site reaction. The place where the vaccine was administered was red, bright swollen & hot. The affected area was 4cm/5cm. Pt is being treated with doxycycline 100mg 1 cap twice a day for 10 days for cellulitis prophylaxis.
Pt received vaccine on 5/18.  On 5/24, noticed arm redness at injection site - became painful, swollen, and tender to touch.  Returned to MD office and was given cortisone cream and possibly a Medrol Dosepak.  On 5/30, noticed numbness/tingling in toes/balls of feet; pain in knees, back, shoulders, and both arms; gradually worsening.  Also noticed LE weakness; had difficulty walking and fell x 2 before seeking treatment in ER.  Transferred to another facility and diagnosed with Guillain Barre syndrome.  Received IVIG therapy.  Currently remains a patient undergoing inpatient rehab.